Sale!

Fabry Disease Quantitative Blood Test

Original price was: $140.Current price is: $88.

-37%

The Fabry Disease Quantitative Blood Test is a specialized diagnostic tool that measures alpha-galactosidase A enzyme activity levels to detect Fabry disease, a rare inherited metabolic disorder. This comprehensive test helps identify individuals with reduced enzyme function, which can lead to the accumulation of harmful substances in the body’s cells. Early detection through this quantitative blood analysis enables timely intervention and management strategies. The test is particularly valuable for individuals experiencing symptoms like neuropathic pain, heat intolerance, skin lesions, or those with a family history of Fabry disease. At only $88 USD, this affordable testing option provides crucial insights into genetic metabolic health and helps guide personalized treatment approaches for better long-term outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Fabry Disease Quantitative Blood Test

Comprehensive Introduction to Fabry Disease Testing

Fabry Disease Quantitative Blood Test represents a cutting-edge diagnostic approach for detecting one of the most significant inherited metabolic disorders affecting individuals worldwide. This specialized laboratory analysis plays a crucial role in identifying Fabry disease, a rare X-linked lysosomal storage disorder caused by deficient activity of the alpha-galactosidase A enzyme. The importance of this quantitative blood test cannot be overstated, as early detection enables healthcare providers to implement timely interventions that can significantly improve patient outcomes and quality of life.

What the Test Measures and Detects

The Fabry Disease Quantitative Blood Test specifically measures the activity levels of alpha-galactosidase A enzyme in blood samples. This enzyme is essential for breaking down specific fatty substances called globotriaosylceramide (Gb3) within the body’s cells. When enzyme activity is significantly reduced or absent, these fatty substances accumulate in various tissues and organs, leading to the progressive symptoms characteristic of Fabry disease.

Key Measurements Include:

  • Quantitative assessment of alpha-galactosidase A enzyme activity
  • Precise measurement of enzyme function levels
  • Identification of enzyme deficiency patterns
  • Correlation with clinical symptoms and disease progression

Who Should Consider This Test

This quantitative blood test is recommended for individuals experiencing symptoms suggestive of Fabry disease or those with known risk factors. Early testing can be particularly beneficial for:

Symptoms and Risk Factors:

  • Individuals experiencing neuropathic pain, especially in hands and feet
  • Patients with heat intolerance and reduced sweating
  • Those with characteristic skin lesions (angiokeratomas)
  • Individuals with gastrointestinal symptoms including abdominal pain and diarrhea
  • Patients with hearing loss or tinnitus
  • Those with corneal opacities or other eye abnormalities
  • Individuals with family history of Fabry disease
  • Patients with unexplained kidney dysfunction or heart problems

Benefits of Taking the Fabry Disease Test

Undergoing the Fabry Disease Quantitative Blood Test offers numerous advantages for patients and healthcare providers alike:

Comprehensive Benefits:

  • Early and accurate diagnosis of Fabry disease
  • Opportunity for timely intervention and treatment initiation
  • Guidance for personalized management strategies
  • Family planning and genetic counseling insights
  • Monitoring of disease progression and treatment effectiveness
  • Prevention of serious complications through early detection
  • Improved quality of life through appropriate symptom management

Understanding Your Test Results

Interpreting Fabry Disease Quantitative Blood Test results requires careful consideration by qualified healthcare professionals. Generally, results fall into several categories:

Result Interpretation Guidelines:

  • Normal Enzyme Activity: Typically indicates absence of Fabry disease
  • Reduced Enzyme Activity: May suggest Fabry disease or carrier status
  • Significantly Low Activity: Strongly indicative of classic Fabry disease
  • Borderline Results: May require additional testing or genetic analysis

It’s important to discuss your specific results with your healthcare provider, who can provide personalized interpretation based on your clinical presentation, family history, and other relevant factors.

Test Pricing Information

Test Name Discount Price Regular Price
Fabry Disease Quantitative Blood Test $88 USD $140 USD

Nationwide Testing Availability

GGC DNA provides comprehensive Fabry Disease Quantitative Blood Testing services across the United States. We have established testing facilities in all major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and Midwest locations
  • Houston and Texas metropolitan areas
  • Phoenix and Arizona testing centers
  • And many additional locations nationwide

Take Action Today

Don’t wait to get the answers you need about your metabolic health. Early detection of Fabry disease can significantly impact treatment outcomes and quality of life. Our experienced team is ready to assist you with convenient testing options and comprehensive support throughout the process.

Book your Fabry Disease Quantitative Blood Test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online through our secure booking portal.

Our commitment to excellence in genetic metabolic testing ensures you receive accurate, reliable results with the professional care and support you deserve. Trust GGC DNA for your specialized diagnostic needs.